Insights from Real-World Analysis of Treatment Patterns in Patients with Newly Diagnosed Knee Osteoarthritis.

Dysart, Stan; Utkina, Karina; Stong, Laura; Nelson, Winnie; Sacks, Naomi; Healey, Bridget; Niazi, Faizan

Dysart, Stan; Utkina, Karina; Stong, Laura; Nelson, Winnie; Sacks, Naomi; Healey, Bridget; Niazi, Faizan.

Afiliação

Dysart S; WellStar Health System Emeritus, Marietta, GA.
Utkina K; Associate Director, Medical Affairs, Orthopaedics and Endocrinology, Ferring Pharmaceuticals, Parsippany, NJ, during the study.
Stong L; Senior Manager, Scientific Training and Publications, Ferring Pharmaceuticals.
Nelson W; Senior Director, HEOR, Ferring Pharmaceuticals, during the study.
Sacks N; Senior Director, Precision Health Economics and Outcomes Research, Boston, MA.
Healey B; Research Scientist, Precision Health Economics and Outcomes Research, Boston, MA.
Niazi F; Director, Medical Affairs, Ferring Pharmaceuticals.

Am Health Drug Benefits ; 14(2): 56-62, 2021 Jun.

Article em En | MEDLINE | ID: mdl-34267860

Palavras-chave

NSAIDs; corticosteroids; intra-articular hyaluronic acid; knee osteoarthritis; opioids; osteoarthritis; treatment guidelines; treatment patterns; utilization patterns

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Revista: Am Health Drug Benefits Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Gabão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google